Copyright
©The Author(s) 2017.
World J Gastroenterol. May 7, 2017; 23(17): 3174-3183
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3174
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3174
Figure 2 Normalization of acid reflux in response to escalating doses of pantoprazole in non-operated patients with Barrett’s esophagus.
1Three patients achieved normalization after switching to esomeprazole 120 mg/d; normalization did not occur in one patient. PPI: Proton pump inhibitors.
- Citation: Baldaque-Silva F, Vieth M, Debel M, Håkanson B, Thorell A, Lunet N, Song H, Mascarenhas-Saraiva M, Pereira G, Lundell L, Marschall HU. Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett’s esophagus. World J Gastroenterol 2017; 23(17): 3174-3183
- URL: https://www.wjgnet.com/1007-9327/full/v23/i17/3174.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i17.3174